China Growth Stocks

[BiotechValues]

well, you both must be looking at different stock then.

The trailing pe is less than many of the high tech companies with patented technology we follow.

A 65% increase in revenues and 104% increase in net income, partnership with one of the world's most venerable companies, and new contracts announced in the month alone that nearly total all revenue for 2008, a solid balance sheet, uplisting pending, and international expansion is something I think makes NFEC a solid as hell buy at $4.